Udayavni Special

New studies reveal HCQ, chloroquine do not show antiviral effect against COVID-19


PTI, Jul 23, 2020, 9:48 AM IST

Chloroquine and hydroxychloroquine, either alone or in combination with the antibiotic azithromycin, do not show any notable antiviral effect against infections with the novel coronavirus in macaques or human lung cells, according to two new studies in the journal Nature.

“Hydroxychloroquine (HCQ) and chloroquine, two drugs, commonly used for the treatment of malaria, have been investigated for their potential to treat COVID-19 in more than 80 registered clinical trials, and have been shown to inhibit the novel coronavirus, SARS-COV-2 infection in cell cultures,” the scientists said.

They said, “However, the effectiveness of these drugs in the treatment of patients with COVID-19 has been debated. In one of the studies, scientists including Roger Le Grand from the French National Institute of Health and Medical Research, assessed the effects of HCQ treatment in cynomolgus macaques, a non-human primate model of SARS-CoV-2 infection in humans.”

They found that HCQ showed no substantial antiviral activity, regardless of the timing of treatment initiation, either before infection, soon after infection, or late after infection. According to the study, using the antimalarial drug in combination with azithromycin, an antibiotic, had no notable effect on virus levels in the macaques either.

In the other study, Stefan Pohlmann and his colleagues from the Leibniz Institute for Primate Research in Germany found that chloroquine has no antiviral activity against SARS-CoV-2 in human lung cells.

They explained that in previous experiments, the cells which were used to demonstrate a positive effect for chloroquine did not have an enzyme that is normally present in human lung cells and facilitates the entry of SARS-CoV-2.

The scientists who conducted this study emphasised the importance of using cell lines which mimic human lung tissue in studies that assess the activity of drugs against SARS-CoV-2.

According to the scientists, these results do not support the use of hydroxychloroquine and chloroquine for the treatment of patients with COVID-19.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

COVID-19: India records 14,849 fresh cases, 155 more fatalities

Puttur: Youth forcibly marries, abducts bethrothed girl

M’luru: Three vehicles damaged after peepal tree near Venkataramana Temple collapses

Sullia: Tree park honouring Salumarada Timmakka opened

India working on 5th-gen fighter, some 6th-gen capabilities will be incorporated in it: IAF chief

Around 25K tractors to participate in ‘kisan parade’ on Republic Day

RLD Chief Lalu Prasad Yadav’s health worsens, airlifted to AIIMS Delhi


Related Articles More

Seven more states to administer Covaxin from next week: Health Ministry

Immune system of recovered COVID-19 patients may evolve to fight SARS-CoV-2 variants says study

COVID-19: 902 new cases in Karnataka, 3 deaths

150 People infected with UK variant of Covid-19 in India, says Govt

COVID-19 vaccine for airport staff in Karnataka

MUST WATCH

The lorry driver’s disaster on the national highway: Hundreds of lives saved | Udayavani

Compol appeals people to share info regarding any untoward developments through Whatsapp

Mangaluru: Police arrest nine students for alleged ragging

Remembering Netaji Subhas Chandra Bose | Asha Raghuvamshi

Inter-state Ganja smuggling racket busted: 7 held, 44.630 kgs of Marijuana seized

Latest Additions

Aviation sector workers be vaccinated on priority after health workers: MoCA to MoHFW

Dubai-based Indian student makes PM Modi’s special portrait as Republic day gift

Seven more states to administer Covaxin from next week: Health Ministry

M-cap of 4 of top-10 valued firms jumps over Rs 1.15 lakh crore; RIL biggest gainer

COVID-19: India records 14,849 fresh cases, 155 more fatalities

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.